Ergoteles’s Incyte INCY Stock Holding History

Ergoteles’s Portfolio INCY Stock Details INCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-8,332	Closed	-$633K	–	1736
2022 Q2	$633K	Buy	+8,332	New	+$633K	0.02%	734
2022 Q1	–	Sell	-213,164	Closed	-$15.6M	–	1414
2021 Q4	$15.6M	Buy	+213,164	New	+$14.4M	0.61%	30
2021 Q3	–	Sell	-12,394	Closed	-$1.04M	–	1428
2021 Q2	$1.04M	Buy	+12,394	New	+$1.03M	0.02%	492
2021 Q1	–	Sell	-6,323	Closed	-$550K	–	919
2020 Q4	$550K	Buy	+6,323	New	+$547K	0.02%	434

Other funds holding INCY

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Ergoteles's INCY Position: Q3 2022 in Review

Ergoteles sold out of Incyte (INCY) in Q3 2022, closing a stake of 8,332 shares — an estimated $633K sold.

Ergoteles first reported a position in INCY in Q4 2020 and held it in 4 quarters. The position peaked at $15.6M in Q4 2021. 537 funds tracked by Wall St. Rank hold INCY as of Q3 2022.

Ergoteles reported no remaining Incyte position as of Q3 2022 after selling out during the quarter.
Ergoteles sold 8,332 Incyte shares in Q3 2022, an estimated $633K.
Ergoteles first reported a position in Incyte in Q4 2020 and held it in 4 quarters.
Ergoteles's Incyte position peaked at $15.6M in Q4 2021.
537 funds tracked by Wall St. Rank held Incyte as of Q3 2022.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.